Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1995-5-4
|
pubmed:abstractText |
Prevalence of type 1 silent myocardial ischemia (SMI; completely asymptomatic patients) is reported to appear 2 to 4% of the general population. The prognosis of these patients is said to be similar to that of patients with angina pectoris. Our study investigated a 10-year follow up of silent myocardial ischemia detected by bicycle exercise testing in comparison to a comparable control group. 10 years later 127 patients were reinvestigated by bicycle ergometry, 33 patients out of the SMI-group (group A) and 84 patients out of the control group (group B). Mean age in group A was 62 +/- 7 years (range 42 to 71 years), in group B 56 +/- 7 years (range 29 to 69 years). After 10 years there was no statistical significant difference between the 2 groups on using beta-blockers, calciumchannel-blockers and nitrates, on arterial hypertension, diabetes mellitus, smoking history and positive family-history as well as in total cholesterol, HDL- and LDL-cholesterol, triglycerides, blood glucose and uric acid. 1 patient of A and 2 of B died from a sudden cardiac death, 2 of A and 7 of B survived a myocardial infarction, 11 of A and 11 of B developed angina pectoris (p < 0.05). A statistical significant difference was found in the ergometric working capacity (maximal workload in Watt) between the 2 groups (p < 0.001) that did not change over the 10 years, the control group worked better in both investigations. SMI type 1, detected by bicycle ergometry seems to be only a risk factor for developing "loud ischemia" (= angina pectoris) but not for "hard events". A routine screening of completely asymptomatic persons with bicycle ergometry seems to have no prognostic relevance.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0303-8173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
89-93
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7701926-Adult,
pubmed-meshheading:7701926-Aged,
pubmed-meshheading:7701926-Angina Pectoris,
pubmed-meshheading:7701926-Cardiovascular Agents,
pubmed-meshheading:7701926-Cause of Death,
pubmed-meshheading:7701926-Exercise Test,
pubmed-meshheading:7701926-Female,
pubmed-meshheading:7701926-Follow-Up Studies,
pubmed-meshheading:7701926-Humans,
pubmed-meshheading:7701926-Male,
pubmed-meshheading:7701926-Middle Aged,
pubmed-meshheading:7701926-Myocardial Infarction,
pubmed-meshheading:7701926-Myocardial Ischemia,
pubmed-meshheading:7701926-Survival Rate
|
pubmed:year |
1994
|
pubmed:articleTitle |
[10-year-follow-up of patients with silent Cohn type 1 myocardial ischemia].
|
pubmed:affiliation |
Abteilung für Kardiologie, Medizinischen Universitätsklinik Graz.
|
pubmed:publicationType |
Journal Article,
English Abstract
|